Ultragenyx Pharmaceutical reported $34.21M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Aptinyx Inc APTX:US $ 2.11M 354K
Bluebird Bio BLUE:US $ 24.86M 3.48M
Epizyme EPZM:US $ 5M 2.91M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Insmed INSM:US $ 31.14M 17.43M
IONIS PHARMACEUT IONS:US $ 10.35M 5.77M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Kyowa Hakko Kirin 4151:JP Y 66265M 9326M
Macrogenics MGNX:US $ 2.61M 1.12M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Moderna Inc MRNA:US 181M 18M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Puma Biotechnology PBYI:US $ 9.84M 2.43M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M
Vital Therapies VTL:US $ 4.12M 0.83M
Xoma XOMA:US $ 1.15M 366K